BKM Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,368
Closed -$77.7K 212
2023
Q4
$77.7K Buy
+2,368
New +$64.4K 0.03% 222

Other funds holding ARKG

BKM Wealth Management's ARKG Position: Q1 2024 in Review

BKM Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 2,368 shares — an estimated $77.7K sold.

BKM Wealth Management first reported a position in ARKG in Q4 2023 and held it in 1 quarter. The position peaked at $77.7K in Q4 2023. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • BKM Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
  • BKM Wealth Management sold 2,368 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $77.7K.
  • BKM Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 1 quarter.
  • BKM Wealth Management's ARK Genomic Revolution ETF position peaked at $77.7K in Q4 2023.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on BKM Wealth Management's 13F filing for Q1 2024, filed 18 Apr 2024.